Brief: Cynata Therapeutics Makes All Employee Positions Redundant Including CEO And MD
06/07/2026 02:47
BRIEF-Cynata Therapeutics Makes All Employee Positions Redundant Including CEO And MD July 6 (Reuters) - Cynata Therapeutics Ltd CYP.AX:
BOARD, MANAGEMENT CHANGES, EXPENDITURE REDUCTIONS, RDTI LOAN
MAKES ALL EMPLOYEE POSITIONS REDUNDANT INCLUDING CEO AND MD EFFECTIVE 6 JULY 2026
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million